The therapeutic potential of nitric oxide in lung transplantation

Chest

Volumn 113, Issue 5, 1998, Pages 1360-1371

  Meyer, Keith C ^a,b   Love, Robert B ^a   Zimmerman, Jerry J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Lung transplantation; Nitric oxide; Peroxynitrites

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD VESSEL TONE; CELL ADHESION; CONDITIONING; GRAFT REJECTION; LUNG TRANSPLANTATION; NONHUMAN; OXIDATION REDUCTION REACTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

EID: 0031950006     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.5.1360     Document Type: Article

References (162)

1. Hardy JD, Webb WR, Dalton ML. Lung liomotransplantation in man. JAMA 1963; 186:1065-74
2. Patterson GA. Historical development of pulmonary transplantation. Semin Respir Crit Care Med 1996; 17:103-07
3. Lynch JP, Trulock EP. Recipient selection. Semin Respir Crit Care Med 1996; 17:109-17
4. Valentine VG, Robbins RC, Berry GJ, et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15:371-83
5. Wekerle T, Klepetko W, Wisser W, et al. Lung retransplantation: institutional report on a series of 20 patients. J Heart Lung Transplant 1996; 15:182-89
6. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988; 255: H1269-75
7. Repine JE, Cheronis JC, Rodell TC, et al. Pulmonary oxygen toxicity and ischemia-reperfusion injury. Am Rev Respir Dis 1987; 136:483-85
8. Hassoun PM, Yu FS, Zulueta JJ, et al. Effect of nitric oxide and cell redox status on the regulation of endothelial cell xanthine oxidase. Am J Physiol 1995; L809-17
9. Furchgott RJ, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-76
10. Palmer RMJ, Ferrige Ag, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-26
11. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84:9265-69
12. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994; 269:13725-28
13. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochem Biophys Acta 1993; 1178:153-75
14. Jia L, Bonaventura C, Bonaventura J, et al. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 1996; 380:221-26
15. Gaston B, Reilly J, Drazen JM, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993; 90:10957-61
16. Weimmalm A, Benthin C, Edlund A, et al. Metabolism and excretion of nitric oxide in humans: an experimental and clinical study. Circ Res 1993; 73:1121-27
17. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43:109-42
18. Stamler JS, Loli E, Roddy MA, et al. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 1994; 89:2035-40
19. Mulligan MS, Moncada S, Ward PA. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis. Br J Pharmacol 1992; 107:1159-62
20. Ialenti A, Moncada S, Di Rosa M. Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993; 110:701-06
21. Miller MJS, Sadowska-Krowicka H, Chotinaruemol S, et al. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993; 263:11-16
22. G-monomethyl-L-arginine. J Exp Med 1994; 179:651-60
23. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-32
24. Thiemermann C, Vane J. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 1990; 182: 591-95
25. Bouchet M, Renaudin MH, Raveau C, et al. Safety requirement for use of inhaled nitric oxide in neonates. Lancet 1993; 341:968-69
26. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992; 258:1898-1902
27. Huie RE, Padmaja S. The reaction of NO with superoxide. Free Radic Res Commun 1993; 18:195-99
28. Royall JA, Kooy NW, Beckman JS. Nitric oxide-related oxidants in acute lung injury. New Horizons 1995; 3:113-22
29. Heffner JE, Repine JE. State of the art: pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140:531-54
30. Radi H, Beckman JS, Bush KM. Peroxynitrite-induced membrane lipid peroxidation; the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288:481-87
31. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288:481-87
32. Radi U, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydryls. J Biol Chem 1991; 266:4244-50
33. Radi R, Rodriguez M, Castro L, et al. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 1994; 308:89-95
34. King PA, Jamison E, Stralis D, et al. Footprinting proteins on DNA with peroxynitrons acid. Nucleic Acids Res 1993; 21:2473-78
35. Hogg N, Kalyanaraman B, Joseph J, et al. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett 1993; 334:170-74
36. Gutierrez HH, Nieves B, Chumley P, et al. Nitric oxide regulation of superoxide-dependent lung injury: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Free Radic Biol Med 1996; 21:43-52
37. Provost P, Lam JY, Lacoste L, et al. Endothelium-derived nitric oxide attenuates neutrophil adhesion to endothelium under arterial flow conditions. Arterioscler Thromb 1994; 14:331-35
38. Liew FY, Millott S, Parkinson C, et al. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J Immunol 1990; 144:4794-97
39. Alspaugh JA, Granger DL. Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis. Infect Immun 1991; 59:2291-96
40. 2. Arch Environ Health 1972; 24:180-88
41. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-24
42. Hogg N, Darley-Usmar VM, Wilson MT, et al. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 1992; 281:419-24
43. Stuehr DJ, Nathan CF. Nitric oxide: a macrophage product responsible for cytostasis and respiratoiy inhibition in tumor target cells. J Exp Med 1989; 169:1543-55
44. Hibbs JB Jr, Taintor RR, Vavrin Z, et al. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988; 157:87-94
45. Lin KT, Xue- JY, Nomen M, et al. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem 1995; 270:16487-90
46. Berlett BS, Ferguet B, Yim MB, et al. Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylations: relevance to signal transduction. Proc Natl Acad Sci USA 1996; 93:1776-80
47. Hoffman RA, Langrehr JM, Billiar TR, et al. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J Immunol 1990; 145: 2220-26
48. Albina JE, Abate JA, Henty WL Jr. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. J Immunol 1991; 147:144-48
49. Efron DT, Kirk SJ, Regan MC, et al. Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery 1991; 110:327-34
50. Stein CS, Strejan GH. Rat splenocytes inhibit antigen-specific lymphocyte proliferation through a reactive nitrogen intermediate (RNI)-dependent mechanism and exhibit increased RNI production in response to IFN-γ. Cell Immunol 1993; 150:281-97
51. Sicher SC, Vazquez MA, Lu CY. Inhibition of macrophage la expression by nitric oxide. J Immunol 1994; 153:1293-1300
52. Hoffman RA, Langrehr JM, Simmons RL. Induction of nitric oxide synthesis during the immune response. In: Ildstad ST, Landes, RG eds. Chimerism and tolerance. Austin, TX: R. G. Landes Co. 1995; 79-84
53. Langrehr JM, Murase N, Markus PM, et al. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat. J Clin Invest 1992; 90:679-83
54. Mulligan MS, Warren JS, Smith CW, et al. Lung injury after deposition of IgA immune complexes: requirements for CDIS and L-arginine. J Immunol 1992; 148:3086-92
55. McCall TB, Palmer RMJ, Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur J Immunol 1991; 21:2523-27
56. Albina JE, Mills CD, Henry WL Jr, et al. Temporal expression of different pathways of L-arginine metabolism in healing wounds. J Immunol 1990; 144:3877-80
57. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88:4651-55
58. Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994; 107:1050-58
59. Kubes P, Granger DN. Nitric oxide modulates microvascular permeability. Am J Physiol 1992; 262:H611-15
60. Kubes P, Kanwar S, Niu X-F, et al. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993; 7:1293-99
61. Abdih H, Kelly CJ, Bouchier-Hayes D. Nitric oxide (endothelium-derived relaxing factor) attenuates revascularization-induced lung injury. J Surg Res 1994; 57:39-43
62. Andrews FJ, Malcontenti-Wilson C, O'Brien PE. Protection against gastric ischemia-reperfusion injury by nitric oxide generators. Dig Dis Sci 1994; 39:366-73
63. Zhang F, White JG, Iadecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J Cereb Blood Flow Metab 1994; 14: 217-26
64. Lefer DJ, Nakanishi K, Johnston WE, Vinten-Johansen J. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 1993; 88:2337-50
65. Guidot DM, Repine MJ, Hybertson BM, et al. Inhaled nitric oxide prevents neutrophil-mediated, oxygen radical-dependent leak in isolated rat lungs. Am J Physiol 1995; 169 (Lung Cell Mol Physiol 13):L2-L5
66. Wu G, Grosnan JT. Macrophages can convert citrulline into arginine. Biochem J 1992; 281:45-48
67. Albina JE, Abate JA, Mastrofrancesco B. Role of ornithine as a proline precursor in healing wounds. J Surg Res 1993; 55:97-102
68. Albina JE, Cui S, Mateo RB, et al. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150:5080-85
69. Werner-Fehnayer G, Werner ER, Fuclis D, et al. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts. J Exp Med 1990; 172:1599-1607
70. Gaston H, Drazen JM, Loscalzo J. et al. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149:538-51
71. Tullett WM, Patel KR. Isosorbide dinitrate and isoxsuprine in exercise induced asthma. BMJ 1983; 280:1934-35
72. Csete M, Chediak A, Abraham W, et al. Airway blood flow modifies allergic airway smooth muscle contraction. Am Rev Respir Dis 1991; 144:59-63
73. Maruyama M, Satoh K, Taira N. Effects of nicorandil and its congeners on musculature und vasculature of the dog trachea in situ. Arch Int Pharmacodyn 1982; 258:260-66
74. Byrick U, Hobbs K, Martineau R, et al. Nitroglycerin relaxes large airways. Anesth Analg 1983; 62:421-25
75. Jansen A, Drazen J, Osborne JA, et al. The relaxant properties in guinea pig airways of S-nitrosothiols. J Pharmacol Exp Ther 1992; 261:154-59
76. Buga GM, Gold ME, Wood KS, et al. Endothelium: derived nitric oxide relaxes nonvascular smooth muscle. Eur J Pharmacol 1989; 161:61-72
77. Dupuy P, Shore S, Drazen J, et al. Bronchodilatory action of inhaled nitric oxide in guinea pigs. J Clin Invest 1992; 90:421-28
78. Kooy NW, Royall JA, Ye YZ, et al. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 1995; 151:1250-54
79. Ignarro LJ, Byrns RE, Buga GM, et al. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61:866-79
80. Lin SF, Crawley DE, Evans TW, et al. Endogenons nitric oxide modulates adrenergic neural vasoconstriction in guinea-pig pulmonary artery. Br J Pharmacol 1991; 104:565-69
81. Namiki A, Yukio H, Ishikawa M, et al. Endothelin-1 and endothelin-3-induced vasorelavation via common generation of endothelin-derived nitric oxide. Life Sci 1992; 50:677-82
82. Frostell C, Fratacci M-D, Wain JC, et al. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83:203S-47
83. Cook JP, Stamler JS, Andon N, et al. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990; 259:H804-12
84. Aviado H, Samaner M, Palecer F, et al. Bronchodilator action of pentaerthrityl tetranitrate in experimental pulmonary embolism. Cardiologia 1968; 52:340-61
85. Dinh-Xuan AT, Higgenboltam TW, Clelland CA, et al. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive pulmonary disease. N Engl J Med 1991; 324:1539-47
86. g-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea pig isolated tracheal smooth muscle. Br J Pharmacol 1990; 100:663-64
87. Belvisi MG, Stretton D, Barnes PJ. Nitric oxide as an endogenous modulator of cholinergie neurotransmission in guinea pig airways. Eur J Pharmacol 1991; 198:219-21
88. Belvisi MG, Stretton CD, Yacoub M, et al. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol 1992; 210:221-22
89. Belvisi MG, Ward JK, Tadjkarimi S, et al. Inhibitory NANC nerves in human airways: differences in disease and after extrinsic denervalion [abstract]. Am Rev Respir Dis 1993; 147:A286
90. Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993; 177:397-407
91. Morris SL, Walsh RC, Hansen JN. Identification and characterization of some bacterial membrane sulfhydryl groups which are targets of bacteriostatic and antibiotic action. J Biol Chem 1984; 259:13590-94
92. Mulligan MS, Hevel JM, Marletta MA, et al. Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc Natl Acad Sci USA 1991; 88:6338-42
93. Haddad IY, Ischiropoulos H, Holm BA, et al. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol 1993; 165(Lung Cell Mol Physiol 9):L555-64
94. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide, Circ Res 1990; 60:1561-75
95. Ladecola C, Pelligrino DA, Moskowitz MA, et al. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1991; 14:175-92
96. Mittal MK, Gupta TK, Lee FY, et al. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994; 267:G416-22
97. Spain DA, Wilson MA, Bar-Natan MF, et al. Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 1994; 36:720-25
98. Chu A, Chambers DE, Lin CC, et al. Effects of inhibition of nitric oxide formation on basal vasoniotion and endothelium-dependent responses of the coronary arteries in awake dogs. J Clin Invest 1991; 87:1964-68
99. Bank N, Aynedjian HS, Khan GA. Mechanism of vasoconstriction induced by chronic inhibition of nitric oxide in rats. Hypertension 1994; 24:322-28
100. Rees DD, Palmer RMJ. Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86:3375-78
101. G-methylarginine, an inhibitor of endothelium derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate the blood pressure in vivo? Biochem Biophys Res Commun 1989; 160:881-86
102. G-methyl-L-arginine inhibits tumor necrosis factor induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-32
103. Hishikawa K, Nakaki T, Tsuda M, et al. Effect of systemic L-arginine administration on hemodynamics and nitric oxide release in man. Jpn Heart J 1992; 33:41-48
104. Baudouin SV, Bath P, Martin JF, et al. L-arginine has no effect on systemic haemodynamics in normal volunteers, or systemic and pulmonary haemodynamics in patients with elevated pulmonary vascular resistance. Br J Pharmacol 1993; 36:45-49
105. Liu SF, Crawley DE, Rohde JAL, et al. Role of nitric oxide and giunosine 3′,5′-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries. Br J Pharmacol 1992; 107:S61-66
106. Fratacci MD, Frostell CG, Chen TY , et al. Inhaled nitric oxide: a selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991; 75: 990-99
107. Pison U, Lopez FA, Heidelmeyer CF, et al. Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange. J Appl Physiol 1993, 74:1287-92
108. Tonz M, von Segesser LK, Schilling J. et al. Treatment of acute pulmonary hypertension with inhaled nitric oxide. Ann Thorac Surg 1994; 58:1031-35
109. Romand J-A, Pinsky MR, Firestone L, et al. Inhaled nitric oxide partially reverses hypoxic pulmonary vasoconstriction in the dog. J Appl Physiol 1994; 76:1350-55
110. Shali NS, Nakayama DK, Jacob TD, et al. Efficacy of inhaled nitric oxide in a porcine model of adult respiratory distress syndrome. Arch Surg 1994; 129:158-64
111. Weitzberg E, Rudehill A, Alving K, et al. Nitric oxide inhalation selectively attenuated pulmonary hypertension and arterial hypoxia in porcine endotoxin shock. Acta Physiol Scand 1991; 143:451-52
112. Ogura H, Cioffi WG, Offner PJ, et al. Effect of inhaled nitric oxider on pulmonary function after sepsis in a swine model. Surgery 1994; 116:313-21
113. Rovira I, Chen TY, Winkler M, et al. Effect of inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of ARDS. J Appl Physiol 1994; 76:345-55
114. Stewart DJ. Endothelial dysfunction in pulmonary vascular disorders. Arzneim-Forsch/Drug Res 1994; 44:451-54
115. Frostell CG, Blomqvist H, Hedenstierna G, et al. Inhaled nitric oxide selectively reverses humann hypoxic pulmonary vasoconstriction without causing systemic vasodilation. An esthesiology 1993; 78:427-35
116. Adnot S, Konyoumdjian C, Defouilloy C, et al. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension. Am Rev Respir Dis 1993; 148:310-16
117. Moinard J, Manier G, Pilet O, et al. Effect of inhaled nitric oxide on hemodynamics and VA/Q inequalities in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 149:1482-87
118. Roberts JD, Lang P, Bigatello LM, et al. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87:447-53
119. Kinsella JP, Neisli SK, Shaffer E, et al. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 1992; 340:819-20
120. Finer NN, Etches PC, Kamstra B, et al. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr 1994; 124:302-08
121. Wessel DL, Adatia I, Ciglia TM, et al. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88(pt 1):2128-38
122. Rich GF, Lowson SM, Johns RA, et al. Inhaled nitric oxide selectively decreases pulmonary vascular resistance without impairing oxygenation during one lung ventilation in patients undergoing cardiac surgery. Anesthesiology 1994; 80:57-62
123. Miller OI, Celermaher DS, Deanfield JE, et al. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994; 108:487-94
124. Journois D, Ponard P, Mauriat P, et al. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 1994; 107:1129-35
125. Girard C, Lehot JJ, Pannetier JC, et al. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77: 880-83
126. Rossaint R, Gerlach H, Schmidt-Rulmke H, et al. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 1995; 107:1107-15
127. Gerlach H, Pappert D, Lewandowski K, et al. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19:443-49
128. Gerlach H, Rossaint R, Pappert D, et al. Time-course and dose response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome. Eur J Clin Invest 1993; 23:499-502
129. Kuo PC, Alfrey EJ, Krieger NR, et al. Differential localization of allogralt nitric oxide synthesis: comparison of liver and heart transplantation in the rat model. Immunology 1996; 87:647-53
130. Ohdan H, Fukuda V, Suzuki S, et al. Simultaneous evaluation of nitric oxide synthesis and tissue oxygenation in rat liver allograft rejection using near-infrared spectroscopy. Transplantation 1995; 60:530-35
131. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181:63-70
132. Winlaw DS, Schyvens CG, Smythe GA, et al. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in grafl survival. Transplantation 1995; 60:77-82
133. Worrall NK, Chang K, Suan GM, et al. Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection. Circ Res 1996; 78:769-79
134. Paul LG, Myllärniemi M, Muzaffar S, et al. Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografls in the ral. Transplantation 1996; 62:1193-95
135. Benvenuli C, Bories PN, Loisance D. Increased serum nitrate concentration in cardiac transplant patients: a marker for acute allograft cellular rejection. Transplantation 1996; 61:745-49
136. Ioannidis I, Hellinger A, Dehmlow C, et al. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 1995; 59:1293-97
137. Devlin J, Palmer RM, Gonde CE, et al. Nitric oxide generation: a predictive parameter of acute allograft rejection. Transplantation 1994; 58:592-95
138. Shiraishi T, DeMeester SR, Worrall NK, et al. Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection. J Thorac Cardiovasc Surg 1995; 110:1449-59
139. Naka Y, Roy DK, Smerling AJ, et al. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg 1995; 110:1434-40
140. Pinsky DJ, Naka Y, Chowdhury NC, et al. The nitric oxide/cyclic CMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 1994; 91:12086-90
141. Katayama Y, Hatanaka K, Hayashi T, et al. Effects of inhaled nitric oxide in single lung transplantation in rats with monocrotaline-induced pulmonary hypertension. J Heart Lung Transplant 1995; 14:486-92
142. Lindberg L, Kimblad PO, Sjoberg T, et al. Inhaled nitric oxide reveals and attenuates endothelial dysfunction after lung transplantation. Ann Thorac Surg 1996; 62:1639-43
143. Adatia I, Lillehei C, Arnold JH, et al. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg 1994; 57:1311-18
144. Macdonald P, Mundy J, Rogers P, et al. Successful treatment of life-threatening acute reperfusion injury after lung transplantation with inhaled nitric oxide. J Thorac Cardiovasc Surg 1995; 110:861-63
145. Date H, Triantafillou AN, Trulock EP, et al. Inhaled nitric oxide reduces human lung allograft dysfunction. J Thorac Cardiovasc Surg 1996; 111:913-19
146. X: an overview. J Toxicol Environ Health 1984; 13:205-27
147. 2-nitrogen in idolated rat lungs. Toxicol Appl Pharmacol 1988; 98:303-12
148. Williams RA, Rhoades HA, Adams WS. The response of lung tissue and surfactant to nitrogen dioxide exposure. Arch Intern Med 1971; 128:101-08
149. Carson JL, Collier AM, Hu SS, et al. Effect of nitrogen dioxide on human nasal epithelium. Am J Respir Cell Mol Biol 1993; 9:264-70
150. Devalia JL, Campbell AM, Supsford RJ, et al. Effect of nitrogen dioxide on synthesis oi inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993; 9:271-78
151. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268:L699-722
152. Szabo C. The pathophysiologic role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6:79-88
153. Kooy NW, Royall JA, Ye YZ, et al. Evidence for in vivo peroxynitrile production in human acute lung injury. Am J Respir Crit Care Med 1995; 151:4250-54
154. Shiel FO. Morbid anatomical changes in the lungs of dogs after inhalation of higher oxides of nitrogen during anesthesia. Br J Anaesth 1967; 39:413-24
155. Hugod C. Ultrastructural changes of the rabbit lung after 5 ppm nitric oxide exposure. Arch Environ Health 1979; 34:12-17
156. Mercer RR, Costa DL, Crapo JD. Alveolar septal injury from low level exposure to nitric oxide [abstract]. Am Rev Respir Dis 1993; 147:A385
157. Kouyoumdjiaii C, Adnot S, Levame M, et al. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. Clin Invest 1994; 94:578-84
158. Groll-Knapp E, Haider M, Kienzl K, et al. Changes in discrimination learning and brain activity (ERP's) due to combined exposure to NO and CO in rats. Toxicology 1988; 49:441-47
159. X). Environ Res 1979; 19:454-62
160. Rossaint K, Pison U, Gerlach H, et al. Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells. Eur Heart J 1993; 14(suppl 1):133-40
161. Kagawa J. Respiratory effects of 2-h exposure to 1.0 ppm nitric oxide in normal subjects. Environ Res 1982; 27:485-90
162. Von Nieding G, Wagnor HM, Krekeler H. Investigation of the acute effects of nitrogen monoxide on lung function in man. In: Proceedings, Third International Clean Air Congress, Dusseldorf: Verlag des Vereins Deutscher Ingenieure, 1973; A14-16